The estimated Net Worth of Samuel F Mckay is at least 1.4 百万$ dollars as of 17 November 2004. Samuel Mckay owns over 36,000 units of Anika Therapeutics stock worth over 873,000$ and over the last 21 years Samuel sold ANIK stock worth over 522,560$.
Samuel has made over 6 trades of the Anika Therapeutics stock since 2004, according to the Form 4 filled with the SEC. Most recently Samuel sold 13,300 units of ANIK stock worth 127,946$ on 19 November 2004.
The largest trade Samuel's ever made was exercising 36,000 units of Anika Therapeutics stock on 17 November 2004 worth over 55,800$. On average, Samuel trades about 12,425 units every 24 days since 2003. As of 17 November 2004 Samuel still owns at least 36,000 units of Anika Therapeutics stock.
You can see the complete history of Samuel Mckay stock trades at the bottom of the page.
Samuel's mailing address filed with the SEC is C/O ANIKA THERAPEUTICS, INC., 160 NEW BOSTON STREET, WOBURN, MA, 01801.
Over the last 21 years, insiders at Anika Therapeutics have traded over 58,649,775$ worth of Anika Therapeutics stock and bought 34,227 units worth 758,329$ . The most active insiders traders include Charles H Sherwood、Farmaceutici S.P.A. Fidia、Joseph H Capper. On average, Anika Therapeutics executives and independent directors trade stock every 47 days with the average trade being worth of 613,258$. The most recent stock trade was executed by Cheryl R Blanchard on 11 March 2024, trading 64,480 units of ANIK stock currently worth 1,563,640$.
who we are we are anika therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. we are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. with over 7 million procedures performed over the past twenty years utilizing our proprietary technology, anika is helping individuals all over the world return to life naturally. our guiding principles we are innovators and creators. we value strong discipline and exceptional focus from our personnel, and we employ lean principles and agile processes in managing our business. this foundation of guiding values, combined with our entrepreneurial spirit, gives anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products. what we do anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care an
Anika Therapeutics executives and other stock owners filed with the SEC include: